Skin cancer is one of the most common forms of cancer worldwide, affecting millions of people every year. It occurs when abnormal skin cells grow uncontrollably, often due to prolonged exposure to ultraviolet (UV) radiation from sunlight. According to findings published in JAMA Dermatology , new evidence highlights the potential of Vitamin B3, specifically its form known as nicotinamide, in reducing the risk of developing skin cancer. While traditional prevention methods such as sunscreen and avoiding excessive sun exposure remain essential, nicotinamide may offer an additional, scientifically supported approach to skin cancer chemoprevention. Cleveland Clinic states that skin cancer begins when DNA within skin cells becomes damaged, leading to abnormal and uncontrolled cell growt

See Full Page